Ceftolozane/tazobactam (acute pyelonephritis) - Benefit assessment according to §35a Social Code Book V

Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
Record ID 32018000841
German
Original Title: Ceftolozan/Tazobactam (akute Pyelonephritis) – Nutzenbewertung gemäß § 35a SGB V
Details
Project Status: Completed
Year Published: 2020
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • Cephalosporins
  • Anti-Infective Agents, Urinary
  • Pyelonephritis
  • Tazobactam
  • Treatment Outcome
  • Urinary Tract Infections
  • Anti-Bacterial Agents
Contact
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.